Skip to main content
PureTech Health plc logo

PureTech Health plc — Investor Relations & Filings

Ticker · PRTC ISIN · GB00BPVG5C82 LEI · 213800LVPDNO2Z9T9I39 IL Manufacturing
Open in API
Filings indexed 1,320 across all filing types
Latest filing 2020-12-11 Major Shareholding Noti…
Country GB United Kingdom
Listing IL PRTC

About PureTech Health plc

https://puretechhealth.com/

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains fields detailing the 'acquisition or disposal of voting rights' by a shareholder ('Invesco Ltd.'). It reports the resulting percentage of voting rights (28.61%) and the total number of voting rights. This structure is characteristic of a major shareholding notification filed with a regulator (FCA, as mentioned in the header) and the issuer. This directly corresponds to the Major Shareholding Notification category (MRQ). The presence of the RNS Number and the RNS footer confirms it is a regulatory announcement.
2020-12-11 English
LYT-100 Advances to Phase 2a Study in Lymphedema
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 1495I' and is dated '10 December 2020'. It contains a press release format announcing clinical trial initiation ('PureTech Initiates Phase 2a trial of LYT-100'). The footer explicitly states, 'This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange.' This structure strongly indicates a general regulatory announcement distributed via the RNS system, which is not a specific financial report like a 10-K, ER, or IR. Since it is a general announcement that doesn't fit the other specific categories (like DIRS, DIV, MANG, etc.), the most appropriate fallback category is Regulatory Filings (RNS). The document length is substantial (9983 chars), but its nature is that of a news release distributed through a regulatory feed, not the comprehensive report itself.
2020-12-10 English
Follica Female Hair Loss Academic Study Published
Environmental & Social Information Classification · 99% confidence The document starts with 'RNS Number : 9939H' and contains standard boilerplate language associated with regulatory news service dissemination, including contact information for Reach and RNS disclaimers at the end. The content itself is an announcement by PureTech Health regarding a positive study result for its Founded Entity, Follica, concerning hair loss treatment. This is a general corporate update disseminated via a regulatory news wire, but it is not a formal financial report (like 10-K or IR), a specific management change (MANG), or a dividend notice (DIV). Since it is a general, timely announcement distributed through the RNS system that doesn't fit a more specific category like ER or CT, the most appropriate classification is the general regulatory announcement fallback, RNS.
2020-12-09 English
PureTech Initiates Ph 2 of LYT-100 in Long COVID
Legal Proceedings Report Classification · 99% confidence The document begins with 'RNS Number : 3566H' and contains standard regulatory boilerplate language at the end, including references to 'Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange.' This strongly indicates a regulatory announcement distributed via the RNS system. The content itself is a press release announcing the initiation of a clinical trial (Phase 2 for LYT-100 in Long COVID). This type of material—a company press release about operational news distributed through a regulatory feed—is best classified as a general Regulatory Filing (RNS), as it does not fit the specific definitions for Earnings Release (ER), Interim Report (IR), or Director's Dealing (DIRS). It is not a short announcement pointing to a larger report, so RPA is less appropriate than RNS for this substantive news release.
2020-12-03 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange'. The content reports the 'Total Voting Rights and Share Capital' as of a specific date (30 November 2020), referencing DTR 5.6.1 of the Disclosure Guidance and Transparency Rules. This type of mandatory, periodic disclosure regarding share structure and voting rights is a standard regulatory announcement. Since it is a specific regulatory update that doesn't fit the definitions for Director's Dealing (DIRS), Major Shareholding Notification (MRQ), or Share Issue/Capital Change (SHA) which usually relate to specific transactions, the most appropriate general category for a routine regulatory disclosure provided via RNS is 'Regulatory Filings' (RNS), as it is a general regulatory announcement. However, upon reviewing the definitions, the content is a specific disclosure about the total number of voting rights, which is a very specific type of regulatory filing. While RNS is a fallback, there isn't a specific code for 'Total Voting Rights Disclosure'. Given the context of RNS distribution and the nature of the disclosure (not a financial report, not a director trade, not a major holding change, but a mandatory disclosure), RNS is the best fit among the provided options, acting as the catch-all for mandatory regulatory news releases.
2020-12-01 English
PureTech to Host Virtual R&D Day for Investors
Report Publication Announcement Classification · 99% confidence The document is an official announcement disseminated via RNS (Regulatory News Service), indicated by the 'RNS Number' and the footer mentioning 'Reach, the non-regulatory press release distribution service of RNS'. The content explicitly announces that PureTech Health PLC will host a 'Virtual R&D Day for Investors' on a specific future date (December 11, 2020) and provides the agenda and registration details. This is not a full financial report (like 10-K or IR), nor is it a transcript (CT) or a standard earnings release (ER). It is an announcement about an upcoming investor event, which falls under the category of general regulatory announcements or investor relations communications. Since it is a formal announcement distributed through the RNS system detailing an upcoming investor event, it best fits the 'Regulatory Filings' (RNS) category as a general corporate disclosure, although 'Investor Presentation' (IP) is related, this document is the *announcement* of the event, not the presentation itself. Given the structure and distribution method, RNS is the most appropriate general classification for this type of corporate news release.
2020-11-30 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.